Skip to main content
RT @LCalabreseDO: Totally down by this but...
what to do about about SSZ??? ( I don't use it anymore but the data are

Leonard Calabrese LCalabreseDO

5 years 11 months ago
Totally down by this but... what to do about about SSZ??? ( I don't use it anymore but the data are weird).... @philipcrobinson @JYazdanyMD @EBRheum @alhkim @CCalabreseDO https://t.co/kYNxxjqL2B
RT @sclerodermaUM: Please join #ACR20 for late breaking abstract on Ziritaxestat, selective autotaxin inhibitor. Phase

Dr. Dinesh Khanna sclerodermaUM

5 years 11 months ago
Please join #ACR20 for late breaking abstract on Ziritaxestat, selective autotaxin inhibitor. Phase 2a trial with stats significant effect on skin score and well tolerated. @UMIntMed Session Date Monday, November 9 Presentation Time: 12:15 PM - 12:30 PM ET
RT @StefanSiebert1: Our paper on body composition in #PsoriaticArthritis #PsA is now published in @RheumJnl

Results sh

Stefan Siebert StefanSiebert1

5 years 11 months ago
Our paper on body composition in #PsoriaticArthritis #PsA is now published in @RheumJnl Results show increased visceral fat in PsA similar to type 2 diabetes in @uk_biobank Important implications for management. @iiiglasgow @UofGICAMS @AMRAMedical https://t.co/6vfkz78tzC
RT @ErinTay61017977: BSR Guidelines and best practice is the top member benefit and reason for joining @RheumatologyUK.

Erin Taylor ErinTay61017977

5 years 11 months ago
BSR Guidelines and best practice is the top member benefit and reason for joining @RheumatologyUK. For anyone who wants to know more about how to get involved with guideline development, this is the perfect opportunity. #MemberEngagement https://t.co/SbskxCzkmI
RT @uptoTate: Newly discovered HGF & HGFAC genes differentiate PsA and PsO in genetic analysis. Could these be impo

Dr. Rachel Tate uptoTate

5 years 11 months ago
Newly discovered HGF & HGFAC genes differentiate PsA and PsO in genetic analysis. Could these be important additional biomarkers for dz? #ABS0500 #ACR20 #ACRbest @RheumNow https://t.co/TNEQo6d6mk https://t.co/bQFBzYmV0J
RT @RHEUMarampa: ACPA+ and subclinical synovitis does not automatically mean developing to RA.

Interesting work by Cleo

sheila RHEUMarampa

5 years 11 months ago
ACPA+ and subclinical synovitis does not automatically mean developing to RA. Interesting work by Cleo Rogier et al. Something to consider in pts w/arthralgias & when to start csDMARDs @RheumNow #ACR20 Abstr#481 #ACRbest https://t.co/q3vIITmtq2
RT @CreakyJoints: Lung disease in primary #SjogrensSyndrome is common; both conditions were diagnosed at the same time i

CreakyJoints.org CreakyJoints

5 years 11 months ago
Lung disease in primary #SjogrensSyndrome is common; both conditions were diagnosed at the same time in 43% of patients, found an #ACR20 study from @joannamarco @GGRheumdoc + @UW @uofcincy colleagues. “Close monitoring is warranted” to make sure lung function is not declining. https://t.co/MpA0Rq2uVR
RT @rheumarhyme: Timezones wont stop international attendees to make #rheum for knowledge at #ACR20. Watch to see @RHEUM
5 years 11 months ago
Timezones wont stop international attendees to make #rheum for knowledge at #ACR20. Watch to see @RHEUMarampa @RichardPAConway @drdavidliew interview @DrSwamyV 🌎🌍🌏 @RheumNow https://t.co/dbIjiLhUnh
RT @drdavidliew: #ACR20 has a fantastic virtual platform & have put in a big effort to make the meeting friendly for

David Liew drdavidliew

5 years 11 months ago
#ACR20 has a fantastic virtual platform & have put in a big effort to make the meeting friendly for international attendees. I had a great chat about it with @DrSwamyV (@ACRheum Chair, Education) @RheumNow with @RichardPAConway @RHEUMarampa Check it out: https://t.co/TDHg0PExBC
RT @MdWarrington: This convinces me! #TNF inhibitors vs #JAKI
great debate at #ACR20 https://t.co/Xb8KkmDJ8f

KenWarringtonMD MdWarrington

5 years 11 months ago
This convinces me! #TNF inhibitors vs #JAKI great debate at #ACR20 https://t.co/Xb8KkmDJ8f
RT @synovialjoints: New treatments in Axial Spa at #ACR20. A significantly higher proportion of pts receiving Upadactini

Dr. Antoni Chan synovialjoints

5 years 11 months ago
New treatments in Axial Spa at #ACR20. A significantly higher proportion of pts receiving Upadactinib vs placebo achieved reductions in all PGA of pain assessments and sustained to week 64 @RheumNow Abstr#369
RT @synovialjoints: Secukinumab has been used to treat spinal involvement in axial SpA. Secukinumab led to significant i

Dr. Antoni Chan synovialjoints

5 years 11 months ago

Secukinumab has been used to treat spinal involvement in axial SpA. Secukinumab led to significant improvements in symptoms of peripheral arthritis in pts with AS. Significant improvements were seen in both tender and swollen joints @RheumNow #ACR20 Abstr#366

RT @RheumNow: Axial Involvement in Psoriatic Arthritis: Perspective by Dr. Eric Ruderman @JointMD

Dr. Eric Ruderman, C

Dr. John Cush RheumNow

5 years 11 months ago
Axial Involvement in Psoriatic Arthritis: Perspective by Dr. Eric Ruderman @JointMD Dr. Eric Ruderman, Chicago, IL., provides his perspective on ACR 2020 coverage of axial involvement in Psoriatic Arthritis. https://t.co/VwrQgirJnE
RT @Sarah_L_Mackie: @drdavidliew @MGHrheumatology @RheumNow That is so interesting. Haptoglobin first described by Paola

Dr Sarah Mackie Sarah_L_Mackie

5 years 11 months ago
@drdavidliew @MGHrheumatology @RheumNow That is so interesting. Haptoglobin first described by Paolaggi et al in early 1980s as having potential to monitor PMR/GCA even when ESR normalised. See link here... https://t.co/ERkhUwssox
RT @drdavidliew: If TCZ blunts CRP a lot/ESR a fair bit, how can we pick GCA relapses in pts on TCZ?

Cool tech (mass sp

David Liew drdavidliew

5 years 11 months ago
If TCZ blunts CRP a lot/ESR a fair bit, how can we pick GCA relapses in pts on TCZ? Cool tech (mass spec w tandem mass tag multiplex) on GiACTA samples. Of 344 candidate proteins, guess what ranked highest? Haptoglobin. Let's validate! @MGHrheumatology #ACR20 ABST0513 @RheumNow https://t.co/ErmqZuf2iu
×